Answers are grounded in this paper and cite their sources.
More than 18% of all lung cancers detected by LDCT in the NLST seem to be indolent, and overdiagnosis should be considered when describing the risks of LDCT screening for lung cancer.
No takes yet. Share an insight, caveat, or question.
Patz et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: